Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Wyoming, Michigan Clinical Trials

A listing of Wyoming, Michigan clinical trials actively recruiting patient volunteers.

RESULTS

Found (4) clinical trials

Sleep for Stroke Management and Recovery Trial

Sleep SMART has a prospective, randomized, open-label, blinded-endpoint (PROBE) design. It is a multi-site, parallel-group superiority trial that compares 6 months of OSA treatment to usual care. The study includes two trials: a prevention study with an embedded recovery trial. 3062 subjects will be randomized over 5 years at 110 ...

Phase N/A

4.5 miles

Learn More »

Blinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic Lymphoma

PRIMARY OBJECTIVES: I. To determine in a randomized manner if the addition of 2 cycles of blinatumomab to standard therapy improves disease-free survival (DFS) in patients with standard risk (SR) B-ALL and higher risk features (SR-High), and patients with standard-risk average (SR-Avg) B-ALL who are negative for minimal residual disease ...

Phase

4.5 miles

Learn More »

Study of CPI-200 in Patients With Advanced Tumors

Primary Objectives: To determine the safety, tolerability and maximum tolerated dose (MTD) of CPI-200 in patients with advanced tumors Secondary Objectives: To evaluate the pharmacokinetics (PK) of CPI-200 To evaluate clinical response and resolution of symptoms after CPI-200 treatment To characterize adverse events of CPI-200 in patients with advanced cancers ...

Phase

8.01 miles

Learn More »

Study of CPI-100 in Patients With Advanced Tumors

Primary Objectives: To determine the safety, tolerability and maximum tolerated dose (MTD) of CPI-100 in patients with advanced tumors Secondary Objectives: To evaluate the pharmacokinetics (PK) of CPI-100 To evaluate clinical response and resolution of symptoms after CPI-100 treatment To characterize adverse events of CPI-100 in patients with advanced cancers ...

Phase

8.01 miles

Learn More »